Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Neoplasms 1Mobility Limitation 1Healthy 1Disease 1Colorectal Neoplasms 1Alzheimer Disease 1

Interventions

fluciclovine F-18 2Positron-Emission Tomography 2Injections 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1ioflupane 1idelalisib 1aflibercept 1Water 1Vertical Dimension 1Methylene Blue 1Mammography 1Drug Delivery Systems 1Diagnosis, Computer-Assisted 1Daunorubicin 1Cytarabine 1Control Groups 1CPX-351 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Disease × Control Groups × Clear all
NCT01844375 2019-11-04

A Trial of Preoperative CHO Drinks on Postoperative Walking Capacity in Colorectal Surgery

Siriraj Hospital

Phase NA Completed
70 enrolled 10 charts
Gastrointestinal

Disease, Colorectal Neoplasms, Mobility Limitation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡